FLC CAPITAL ADVISORS – Gilead Sciences, Inc. Transaction History
FLC CAPITAL ADVISORS portfolio value:
$201,000
portfolio value
FLC CAPITAL ADVISORS quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -42.13% | -2.37K shares | -147K | $61.69 | 3.25K |
Q2 2022 | share | 0.00% | 0 shares | 14K | $61.81 | 5.62K | |
Q1 2022 | share | Decrease | -21.05% | -1.5K shares | -183K | $59.45 | 5.62K |
Q4 2021 | share | Decrease | -37.60% | -4.29K shares | -281K | $73.36 | 7.12K |
Q3 2021 | share | Decrease | -4.19% | -500 shares | -23K | $69.85 | 11.41K |
Q2 2021 | share | 0.00% | 0 shares | 51K | $68.17 | 11.91K | |
Q1 2021 | share | Increase | +8.66% | 950 shares | 131K | $63.33 | 11.91K |
Q4 2020 | share | Increase | +51.95% | 3.75K shares | 202K | $56.43 | 10.96K |
Q3 2020 | share | Increase | 0.00% | 7.21K shares | 437K | $60.52 | 7.21K |